These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30546040)

  • 1. Characterisation of small molecule ligands 4CMTB and 2CTAP as modulators of human FFA2 receptor signalling.
    Schofield ZV; Croker D; Robertson AAB; Massey NL; Donovan C; Tee E; Edwards D; Woodruff TM; Halai R; Hansbro PM; Cooper MA
    Sci Rep; 2018 Dec; 8(1):17819. PubMed ID: 30546040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and functional characterization of allosteric agonists for the G protein-coupled receptor FFA2.
    Lee T; Schwandner R; Swaminath G; Weiszmann J; Cardozo M; Greenberg J; Jaeckel P; Ge H; Wang Y; Jiao X; Liu J; Kayser F; Tian H; Li Y
    Mol Pharmacol; 2008 Dec; 74(6):1599-609. PubMed ID: 18818303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Allosteric Activator of Free Fatty Acid 2 Receptor Displays Unique Gi-functional Bias.
    Bolognini D; Moss CE; Nilsson K; Petersson AU; Donnelly I; Sergeev E; König GM; Kostenis E; Kurowska-Stolarska M; Miller A; Dekker N; Tobin AB; Milligan G
    J Biol Chem; 2016 Sep; 291(36):18915-31. PubMed ID: 27385588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetate protects against intestinal ischemia-reperfusion injury independent of its cognate free fatty acid 2 receptor.
    Schofield ZV; Wu MCL; Hansbro PM; Cooper MA; Woodruff TM
    FASEB J; 2020 Aug; 34(8):10418-10430. PubMed ID: 32725930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first synthetic agonists of FFA2: Discovery and SAR of phenylacetamides as allosteric modulators.
    Wang Y; Jiao X; Kayser F; Liu J; Wang Z; Wanska M; Greenberg J; Weiszmann J; Ge H; Tian H; Wong S; Schwandner R; Lee T; Li Y
    Bioorg Med Chem Lett; 2010 Jan; 20(2):493-8. PubMed ID: 20005104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular ionic locks determine variation in constitutive activity and ligand potency between species orthologs of the free fatty acid receptors FFA2 and FFA3.
    Hudson BD; Tikhonova IG; Pandey SK; Ulven T; Milligan G
    J Biol Chem; 2012 Nov; 287(49):41195-209. PubMed ID: 23066016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3.
    Schmidt J; Smith NJ; Christiansen E; Tikhonova IG; Grundmann M; Hudson BD; Ward RJ; Drewke C; Milligan G; Kostenis E; Ulven T
    J Biol Chem; 2011 Mar; 286(12):10628-40. PubMed ID: 21220428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonism and allosterism: the pharmacology of the free fatty acid receptors FFA2 and FFA3.
    Milligan G; Stoddart LA; Smith NJ
    Br J Pharmacol; 2009 Sep; 158(1):146-53. PubMed ID: 19719777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the molecular basis for the first potent and selective orthosteric agonists of the FFA2 free fatty acid receptor.
    Hudson BD; Due-Hansen ME; Christiansen E; Hansen AM; Mackenzie AE; Murdoch H; Pandey SK; Ward RJ; Marquez R; Tikhonova IG; Ulven T; Milligan G
    J Biol Chem; 2013 Jun; 288(24):17296-312. PubMed ID: 23589301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, Activity, and Docking Study of Novel Phenylthiazole-Carboxamido Acid Derivatives as FFA2 Agonists.
    Ma L; Wang T; Shi M; Fu P; Pei H; Ye H
    Chem Biol Drug Des; 2016 Jul; 88(1):26-37. PubMed ID: 26808470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation.
    Le Poul E; Loison C; Struyf S; Springael JY; Lannoy V; Decobecq ME; Brezillon S; Dupriez V; Vassart G; Van Damme J; Parmentier M; Detheux M
    J Biol Chem; 2003 Jul; 278(28):25481-9. PubMed ID: 12711604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs.
    Hudson BD; Christiansen E; Tikhonova IG; Grundmann M; Kostenis E; Adams DR; Ulven T; Milligan G
    FASEB J; 2012 Dec; 26(12):4951-65. PubMed ID: 22919070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemogenetics defines a short-chain fatty acid receptor gut-brain axis.
    Barki N; Bolognini D; Börjesson U; Jenkins L; Riddell J; Hughes DI; Ulven T; Hudson BD; Ulven ER; Dekker N; Tobin AB; Milligan G
    Elife; 2022 Mar; 11():. PubMed ID: 35229717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of the free fatty acid receptor 2 (FFA2) and a novel functional FFA2-like receptor (FFA2L) for short-chain fatty acids in pigs: evidence for the existence of a duplicated FFA2 gene (FFA2L) in some mammalian species.
    Zhang J; Cheng S; Wang Y; Yu X; Li J
    Domest Anim Endocrinol; 2014 Apr; 47():108-18.e1. PubMed ID: 24315753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GABA
    Olianas MC; Dedoni S; Onali P
    Eur J Pharmacol; 2017 Jan; 794():135-146. PubMed ID: 27876620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-chain fatty acid receptors involved in epithelial acetylcholine release in rat caecum.
    Ballout J; Akiba Y; Kaunitz JD; Diener M
    Eur J Pharmacol; 2021 Sep; 906():174292. PubMed ID: 34216575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic AMP signaling as a mediator of vasculogenic mimicry in aggressive human melanoma cells in vitro.
    Lissitzky JC; Parriaux D; Ristorcelli E; Vérine A; Lombardo D; Verrando P
    Cancer Res; 2009 Feb; 69(3):802-9. PubMed ID: 19176384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tonic inhibitory role for cAMP in alpha(1a)-adrenergic receptor coupling to extracellular signal-regulated kinases 1/2.
    Jiao X; Gonzalez-Cabrera PJ; Xiao L; Bradley ME; Abel PW; Jeffries WB
    J Pharmacol Exp Ther; 2002 Oct; 303(1):247-56. PubMed ID: 12235258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets.
    Ulven T
    Front Endocrinol (Lausanne); 2012; 3():111. PubMed ID: 23060857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells.
    Li M; van Esch BCAM; Wagenaar GTM; Garssen J; Folkerts G; Henricks PAJ
    Eur J Pharmacol; 2018 Jul; 831():52-59. PubMed ID: 29750914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.